Josh Ludwig

Global director, commercial operations, ScaleReady

Articles by Josh Ludwig

Improving Practicality of Cell and Gene Therapies

October 26th 2021

Josh Ludwig, global director, commercial operations, ScaleReady, discussed making cell and gene therapy widely practical and viable for patients with cancer.

Josh Ludwig

Articles by Josh Ludwig

Improving Practicality of Cell and Gene Therapies

Latest Updated Articles

Trending on CGTlive®

AAVantgarde’s Stargardt Gene Therapy AAVB-039 Garners FDA Orphan Drug Designation, Cleared for Trial in UK

Around the Helix: Cell and Gene Therapy Company Updates – October 22, 2025

AskBio’s Heart Failure Gene Therapy AB-1002 Shows Ability to Improve NYHA Class in Phase 1 Trial